Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Can biochemical markers discriminate between new-onset type 1 and type 2 diabetes mellitus in children?

Nature Clinical Practice Endocrinology & Metabolism volume 3, pages 800–801 (2007)Cite this article

boxed-textLevitt Katz LE et al. (2007) Fasting c-peptide and insulin-like growth factor-binding protein-1 levels help to distinguish childhood type 1 and type 2 diabetes mellitus at diagnosis. Pediatr Diabetes 8: 53–59

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. American Diabetes Association (2007) Diagnosis and classification of diabetes mellitus. Diabetes Care 30 (Suppl 1): S42–S47

  2. Ogden CL et al. (2006) Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 295: 1549–1555

    Article  CAS  Google Scholar 

  3. Fagot-Campagna A et al. (2000) Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr 136: 664–672

    Article  CAS  Google Scholar 

  4. Liese AD et al. (2006) The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics 118: 1510–1518

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Division of Endocrinology, Children's Hospital Boston, 300 Longwood Avenue, Boston, MA 02115, USA joseph.wolfsdorf@childrens.harvard.edu

Authors and Affiliations

  1. JI Wolfsdorf is the Director of the Diabetes Program; Clinical Director and Associate Chief of the Division of Endocrinology, Children's Hospital Boston, MA, USA.,

    Joseph I Wolfsdorf

  2. Clinical Director and Associate Chief of the Division of Endocrinology, Children's Hospital Boston, MA, USA.,

    Joseph I Wolfsdorf

Authors
  1. Joseph I Wolfsdorf
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wolfsdorf, J. Can biochemical markers discriminate between new-onset type 1 and type 2 diabetes mellitus in children?. Nat Rev Endocrinol 3, 800–801 (2007). https://doi.org/10.1038/ncpendmet0642

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0642

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing